ChartRow logo
ONC
$386.49+0.52%
as of close, Oct 21, 2026
☾ AH $386.49 +0.52%
BeOne Medicines Ltd. American Depositary SharesStock · Healthcare
Share this page

ONC financial statements

The full income statement, balance sheet, and cash-flow statement for BeOne Medicines Ltd. American Depositary Shares (ONC), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 106.1M2024-09 106.6M2024-12 106.7M2025-03 107.9M2025-06 110.0M2025-09 110.7M2025-12 110.9M2026-03 111.2M2026-06 113.7M+7.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue5.34B+40.2%3.81B+55.0%2.46B+73.7%1.42B+20.4%1.18B+280.8%
4.67B+45.3%3.22B+54.7%2.08B+84.1%1.13B+11.7%1.01B
Cost of revenue———286M+73.7%165M+133.4%
Research & development2.15B+9.9%1.95B+9.8%1.78B+8.4%1.64B+12.4%1.46B+12.7%
Selling, general & administrative2.08B+13.7%1.83B+21.4%1.51B+17.9%1.28B+29.1%990M+65.0%
Amortization of intangibles10.1M+108.8%4.82M-33.4%7.24M+82.1%3.98M+131.8%1.72M+102.7%
Provision for credit losses———-219K-170.9%309K+183.5%
Operating income447M+178.7%-568M+53.0%-1.21B+32.5%-1.79B-24.4%-1.44B+13.2%
Interest expense50.0M+129.1%21.8M+399.7%4.36M-79.9%21.7M-25.8%29.3M+59.8%
Interest & investment income70.5M+1.2%69.6M-11.1%78.4M——
Net interest income——74.0M+41.0%52.5M+433.1%-15.8M-888.6%
Other non-operating income-42.6M-236.7%-12.6M-104.1%308M+237.5%-224M-1507.5%15.9M-57.6%
Equity-method income——-16.2M+26.3%-22.0M-388.2%7.63M-35.5%
Gain (loss) on equity securities
-74.5M————
Pre-tax income417M+178.2%-533M+35.5%-826M+57.9%-1.96B-36.3%-1.44B+11.1%
Income tax130M+16.2%112M+100.1%55.9M+30.6%42.8M+122.5%19.2M+84.9%
287M+144.5%-645M+26.9%-882M+56.0%-2.00B-37.5%-1.46B+10.3%
Net income to non-controlling interest———0.000.00+100.0%
$2.47+140.4%-$6.11+27.7%-$8.45+56.4%-$19.37-23.1%-$15.73+19.3%
EPS (basic)$2.60+142.6%-$6.11+27.7%-$8.45+56.4%-$19.37-23.1%-$15.73+19.3%
Weighted-avg shares (basic)109M+3.6%105M+0.9%104M+1.2%103M+11.2%92.8M+11.2%
Weighted-avg shares (diluted)113M+7.8%105M+0.9%104M+1.2%103M+11.2%92.8M+11.2%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
6.23B+56.2%3.99B-5.0%4.20B-19.3%5.21B-31.6%7.61B+53.5%
Cash & equivalents4.55B+73.1%2.63B-17.2%3.17B-18.0%3.87B-11.6%4.38B+216.6%
Short-term investments——2.60M-99.6%665M-70.3%2.24B-31.4%
Accounts receivable865M+27.9%676M+88.9%358M+106.8%173M-64.2%483M+699.8%
Inventory608M+22.9%495M+19.0%416M+47.4%282M+16.4%243M+171.7%
Prepaid expenses213M+10.3%193M-25.1%257M+18.9%217M-19.8%270M+68.8%
Other current assets
————27.1M+132.0%
8.19B+38.3%5.92B+2.0%5.81B-9.0%6.38B-25.3%8.54B+52.4%
Property, plant & equipment1.64B+4.0%1.58B+19.2%1.32B+56.5%846M+44.0%588M+64.3%
Operating lease right-of-use148M+6.4%139M+46.3%95.2M-13.4%110M-6.4%117M+29.6%
Goodwill———109K+0.0%109K+0.0%
Intangible assets62.7M+22.7%51.1M-10.6%57.1M+40.7%40.6M-13.0%46.7M+833.6%
Long-term investments61.7M-52.2%129M+43.8%89.6M-2.3%91.8M-8.9%101M+104.3%
Deferred tax assets
————0.00-100.0%
Other non-current assets102M-36.2%160M+28.0%125M-28.6%176M+7.8%163M+44.2%
Total non-current assets1.95B+1.3%1.93B+20.4%1.60B+36.7%1.17B+27.2%922M+44.0%
1.83B-17.4%2.21B+22.4%1.81B+23.3%1.47B-8.2%1.60B+48.8%
Accounts payable479M+18.3%405M+28.5%315M+6.9%295M+12.3%262M+13.1%
Accrued liabilities1.11B+38.0%804M+15.9%694M+48.4%467M-16.3%558M+61.2%
Deferred revenue——0.00-100.0%214M+14.1%187M
Short-term & current debt57.3M-93.3%852M+23.7%688M+109.2%329M-23.1%428M+27.6%
Current lease liability20.7M+17.8%17.6M-19.9%21.9M-8.7%24.0M+9.7%21.9M+57.8%
Other current liabilities33.6M+52.9%22.0M———
3.83B+47.9%2.59B+14.1%2.27B+13.6%2.00B-16.9%2.40B+38.8%
Long-term debt962M+477.8%166M-15.8%198M-5.5%209M+3.5%202M+10.1%
Deferred revenue (non-current)——300K-99.3%42.0M-80.9%220M
Non-current lease liability52.9M+19.6%44.3M+99.0%22.3M-35.5%34.5M-19.8%43.0M+46.3%
Operating lease liability (total)73.6M+19.1%61.9M+39.9%44.2M-24.5%58.6M-9.9%65.0M+50.0%
Deferred tax liabilities53.2M+26.7%42.0M+154.7%16.5M+3.1%16.0M+12.9%14.2M+31.3%
Other non-current liabilities80.2M+20.2%66.7M+31.3%50.8M+10.2%46.1M-15.0%54.2M-5.6%
Total non-current liabilities2.00B+434.7%374M-18.4%458M-13.2%527M-34.4%803M+22.4%
4.36B+30.9%3.33B-5.8%3.54B-19.3%4.38B-28.5%6.13B+58.5%
Common stock144K+4.3%138K+2.2%135K+0.0%135K+1.5%133K+12.7%
Additional paid-in capital12.8B+5.6%12.1B+4.2%11.6B+0.5%11.5B+3.1%11.2B+50.9%
Retained earnings-8.32B+3.3%-8.61B-8.1%-7.96B-12.5%-7.08B-39.5%-5.08B-42.9%
Accumulated other comprehensive income-78.2M+47.5%-149M-49.8%-99.4M-28.5%-77.4M-531.3%17.9M+158.6%
Total equity incl. non-controlling——3.54B-19.3%4.38B-28.5%6.13B+61.2%
Total liabilities & equity8.19B+38.3%5.92B+2.0%5.81B-9.0%6.38B-25.3%8.54B+52.4%
Common shares issued119M+11.1%107M+2.0%105M+0.2%104M+1.6%103M+12.1%
Common shares outstanding111M+3.9%107M+2.0%105M+0.2%104M+1.6%103M+12.1%
Shares outstanding (cover)111M+4.0%107M+2.0%105M+0.2%104M+1.6%103M+12.1%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.13B+901.8%-141M+87.8%-1.16B+22.7%-1.50B-15.2%-1.30B-1.2%
Depreciation & amortization142M-17.5%172M+95.9%87.7M+32.3%66.3M+42.7%46.5M+46.1%
Intangible amortization10.1M+108.8%4.82M-33.4%7.24M+82.1%3.98M+131.8%1.72M+102.7%
Share-based compensation511M+15.7%442M+20.1%368M+21.3%303M+25.9%241M+31.2%
Deferred income taxes9.47M-63.6%26.0M+3685.6%687K-80.3%3.48M+9.5%3.18M+2889.5%
Change in receivables165M-49.9%329M+75.0%188M+161.9%-304M-171.9%423M+4182.0%
Change in inventory93.2M+1.8%91.5M-35.1%141M+148.6%56.7M-63.0%153M+160.3%
Change in payables79.8M-34.3%121M+465.5%21.5M+593.7%-4.35M-121.8%20.0M-79.1%
Other operating activities-2.95M-126.5%11.2M+286.1%-6.00M-166.3%9.05M-61.5%23.5M+603.1%
-276M+49.6%-548M-1013.9%60.0M-94.4%1.08B+68.1%641M+120.2%
Capital expenditure186M-62.3%493M-12.3%562M+72.7%325M+23.8%263M+123.8%
Free cash flow942M+248.7%-633M+63.2%-1.72B+5.6%-1.82B-16.7%-1.56B-11.5%
Acquisitions0.000.000.000.000.00
Other investing activities1.24M-56.8%2.86M+37.9%2.08M+39.7%1.49M0.00-100.0%
1.06B+447.7%193M-53.6%416M+2295.3%-19.0M-100.5%3.64B-30.1%
Long-term debt issued0.000.000.000.000.00-100.0%
Long-term debt repaid35.7M+27.3%28.0M+104.8%13.7M0.000.00-100.0%
Common stock issued0.000.000.000.00-100.0%50.0M-98.8%
Common stock repurchased0.000.000.000.000.00
Dividends paid0.000.000.000.000.00
Other financing activities0.00-100.0%3.00M0.000.00—
FX effect on cash60.0M+216.1%-51.7M-539.8%-8.08M+88.4%-69.4M-594.4%14.0M-23.0%
Net change in cash1.97B+460.2%-547M+20.6%-689M-35.7%-508M-117.0%2.99B+289.1%
Interest paid34.4M+74.6%19.7M+466.1%3.48M+15392.0%22.5K-99.9%30.0M-32.1%
Income taxes paid101M+45.0%69.4M+24.0%56.0M+89.8%29.5M+88.0%15.7M+48.1%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap33.7B+71.0%19.7B+4.5%18.9B-17.4%22.8B-17.9%27.8B+17.5%
P/E
117.5×————
P/S6.3×+21.9%5.2×-39.5%8.6×-53.2%18.3×-22.7%23.6×-69.1%
P/B7.7×+30.6%5.9×+18.0%5.0×+2.2%4.9×+8.1%4.5×-25.8%
P/FCF
35.8×————
Earnings yield
0.85%————
FCF yield
2.8%————
Source filing10-K10-K10-K10-K10-K

About this data

Source: ONC’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ONC filings on SEC EDGAR → Not investment advice.